Healthsouth Corp. (HLS) Tops Q1 EPS by 3c; Sees FY12 EPS At or Above Prior Outlook
Tweet
Share
E-mailGet Alerts HLS Hot Sheet
Price: $49.41 --0%
Financial Fact:
Total operating expenses: 749.9M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Financial Fact:
Total operating expenses: 749.9M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Join SI Premium – FREE
Healthsouth Corp. (NYSE: HLS) reported Q1 EPS of $0.40, $0.03 better than the analyst estimate of $0.37. Revenue for the quarter came in at $538.6 million versus the consensus estimate of $525.84 million.
Based on its results for the first quarter of 2012, the Company expects its 2012 full-year results to be at the high end of, or higher than, prior guidance.
For earnings history and earnings-related data on Healthsouth Corp. (HLS) click here.
Based on its results for the first quarter of 2012, the Company expects its 2012 full-year results to be at the high end of, or higher than, prior guidance.
For earnings history and earnings-related data on Healthsouth Corp. (HLS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Karyopharm Therapeutics (KPTI) Misses Q2 EPS by $1.01, Beats on Revenue; Offers FY26 Revenue Guidance
- Beyond Air, Inc. (XAIR) Tops Q1 reported Q1 Revenue ; Offers Guidance
- McGraw Hill (MH) Tops Q2 EPS by 11c, Beats on Revenue; Offers FY26 Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
